Scroll Top

Genomics: gearing up for the laboratory of the future

A giant step forward has been taken, as the first next-generation sequencer for clinical care received FDA marketing authorization this past November. This advance means clinicians can start to look for “an almost unlimited number of genetic changes” in patients’ DNA, wrote NIH director Francis S. Collins and FDA Commissioner Margaret A. Hamburg in the New England Journal of Medicine article that announced the launch.1More such instruments will follow.

Link to Article:

Related Posts